Candel Therapeutics (CADL) Net Margin (QoQ) (2020 - 2022)

Candel Therapeutics (CADL) Net Margin (QoQ) (2020 - 2022) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Candel Therapeutics 542.51 Mn 542.51 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2022 173,548.00
Sep 30, 2022 19,677.00
Jun 30, 2022 9.37 Mn
Mar 31, 2022 31.17 Mn
Dec 31, 2021 -40.93 Mn
Sep 30, 2021 -832,903.00
Jun 30, 2021 -208,710.00
Mar 31, 2021 4.11 Mn
Dec 31, 2020 -4.73 Mn
Sep 30, 2020 -142,258.00